Literature DB >> 7575759

Quantitative determination of lectins in mistletoe preparations.

C Jäggy1, H Musielski, K Urech, G Schaller.   

Abstract

Assay of lectins in mistletoe preparations was based on an improved and validated version of ELLA (enzyme-linked lectin assay) to meet the requirements given in the guidelines for drug tests. The monoclonal antibody used has more than 90% cross reactivity with the three known mistletoe lectins, so that total lectin content is determined with much greater accuracy. With the detection and quantitative analysis limit below 5 ng/ml and a linear measuring range of 5-50 ng/ml, dosages in therapeutic range can be assayed. Tests to establish the accuracy of the analytical method showed that up to 26% of lectin activity is suppressed by other constituents of the extract, so that the recovery must be taken into account. The recovery increases following ultrafiltration to remove low-molecular constituents. Analysis for precision gave a variation coefficient of < or = 7.7% and a confidence interval < or = 5.7% (p = 0.05) for total lectin concentrations of approx. 250 ng/ml. This level of precision, which is good for an immunologic assay, makes it possible to standardize mistletoe preparations.

Mesh:

Substances:

Year:  1995        PMID: 7575759

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  12 in total

1.  Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2.

Authors:  E C Lavelle; G Grant; A Pusztai; U Pfüller; O Leavy; E McNeela; K H G Mills; D T O'Hagan
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

2.  Viscotoxin and lectin content in foliage and fruit of Viscum album L. on the main host trees of Hyrcanian forests.

Authors:  Sanaz Yousefvand; Farnoosh Fattahi; Seyed Mohsen Hosseini; Konrad Urech; Gerhard Schaller
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

3.  Unexpected different binding of mistletoe lectins from plant extracts to immobilized lactose and N-acetylgalactosamine.

Authors:  Tibor Hajtò; Fodor Krisztina; Aponyi Ildikò; Pallai Zsolt; Balogh Pèter; Németh Pèter; Perjési Pàl
Journal:  Anal Chem Insights       Date:  2007-09-17

4.  Adverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer Patients.

Authors:  Megan L Steele; Jan Axtner; Antje Happe; Matthias Kröz; Harald Matthes; Friedemann Schad
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-19       Impact factor: 2.629

5.  Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients.

Authors:  Paul R Bock; Jürgen Hanisch; Harald Matthes; Kurt S Zänker
Journal:  Inflamm Allergy Drug Targets       Date:  2014

6.  Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells.

Authors:  Katharina Mulsow; Thomas Enzlein; Catharina Delebinski; Sebastian Jaeger; Georg Seifert; Matthias F Melzig
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

7.  Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma.

Authors:  Monika Twardziok; Susann Kleinsimon; Jana Rolff; Sebastian Jäger; Angelika Eggert; Georg Seifert; Catharina I Delebinski
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

8.  Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model.

Authors:  Carmen Steinborn; Amy Marisa Klemd; Ann-Sophie Sanchez-Campillo; Sophie Rieger; Marieke Scheffen; Barbara Sauer; Manuel Garcia-Käufer; Konrad Urech; Marie Follo; Annekathrin Ücker; Gunver Sophia Kienle; Roman Huber; Carsten Gründemann
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

9.  A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo.

Authors:  Catharina I Delebinski; Monika Twardziok; Susann Kleinsimon; Florian Hoff; Katharina Mulsow; Jana Rolff; Sebastian Jäger; Angelika Eggert; Georg Seifert
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

10.  GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway.

Authors:  Susann Kleinsimon; Enya Longmuss; Jana Rolff; Sebastian Jäger; Angelika Eggert; Catharina Delebinski; Georg Seifert
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.